Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

Rationale: The Scleroderma Lung Study enrolled 158 patients with scleroderma-related interstitial lung disease in a placebo-controlled trial of oral cyclophosphamide (CYC). Although treatment-related benefits in pulmonary function, skin scores, and patient-centered outcomes were demonstrated after 1...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Tashkin, Donald P., Elashoff, Robert, Clements, Philip J., Roth, Michael D., Furst, Daniel E., Silver, Richard M., Goldin, Jonathan, Arriola, Edgar, Strange, Charlie, Bolster, Marcy B., Seibold, James R., Riley, David J., Hsu, Vivien M., Varga, John, Schraufnagel, Dean, Theodore, Arthur, Simms, Robert, Wise, Robert, Wigley, Fred, White, Barbara, Steen, Virginia, Read, Charles, Mayes, Maureen, Parsley, Ed, Mubarak, Kamal, Connolly, M. Kari, Golden, Jeffrey, Olman, Mitchell, Fessler, Barri, Rothfield, Naomi, Metersky, Mark, Khanna, Dinesh, Li, Ning, Li, Gang
Format: Artigo
Sprog:Inglês
Udgivet: American Thoracic Society 2007
Fag:
E. Interstitial Lung Disease
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2078679/
https://ncbi.nlm.nih.gov/pubmed/17717203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200702-326OC
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker